Question 1

What is the catalog number for Trelagliptin Impurity 21?

Accepted Answer

The catalog number for Trelagliptin Impurity 21 is RM-T120847.

Question 2

What sizes are available for Trelagliptin Impurity 21?

Accepted Answer

Trelagliptin Impurity 21 is available in the following size(s): 10 mg, 25 mg, 50 mg, 100 mg.

Question 3

How many pack sizes does Trelagliptin Impurity 21 come in?

Accepted Answer

Trelagliptin Impurity 21 is available in 4 different pack sizes.

Question 4

Is Trelagliptin Impurity 21 in stock?

Accepted Answer

Trelagliptin Impurity 21 is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 6

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 7

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Trelagliptin Impurity 21

Product Specifications

CAS Number

Synonyms

Molecular Formula

Molecular Weight

Target Alternative Name

Product Name Synonym

Available Sizes

Frequently Asked Questions

Explore Other Products

TIM3 / HAVCR2 / CD366 (Effector T-Cell Marker) (TIM3/3113), CF740 conjugate, 0.1mg/mL

Anti-Human IgG Antibody (HRP)

Anti-Human IgG Antibody (HRP)

Anti-Human IgG Antibody (HRP)

IRAG1 Human Gene Knockout Kit (CRISPR)

Itgb1 Mouse Gene Knockout Kit (CRISPR)